Cargando…
Presence or absence of ocular surface inflammation directs clinical and therapeutic management of dry eye
BACKGROUND: The presence of clinically significant inflammation has been confirmed in the tears of 40%–65% of patients with symptoms of dry eye. Ocular surface inflammation may lead to tear film instability, epithelial cell irregularities, and permeability, resulting in chronic symptomatic pain and...
Autor principal: | Sambursky, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127432/ https://www.ncbi.nlm.nih.gov/pubmed/27920494 http://dx.doi.org/10.2147/OPTH.S121256 |
Ejemplares similares
-
Special Issue “Diagnosis and Management of Dry Eye Disease and Ocular Surface Inflammation”
por: Giannaccare, Giuseppe, et al.
Publicado: (2022) -
Dry Eye Management: Targeting the Ocular Surface Microenvironment
por: Zhang, Xiaobo, et al.
Publicado: (2017) -
Lacrimal Gland, Ocular Surface, and Dry Eye
por: Ding, Chuanqing, et al.
Publicado: (2016) -
Analysis of the Pathogenic Factors and Management of Dry Eye in Ocular Surface Disorders
por: Nebbioso, Marcella, et al.
Publicado: (2017) -
Autophagy in dry eye disease: Therapeutic implications of autophagy modulators on the ocular surface
por: Jeyabalan, Nallathambi, et al.
Publicado: (2023)